Clinical Trials Logo

Clinical Trial Summary

This prospective and retrospective registry will evaluate the clinical effectiveness of Germline Genetic, Genomic, and other Biomarker testing results over time in different clinical populations, in order to shape guidelines for testing, patient management, and precision therapy.


Clinical Trial Description

Interest and knowledge about the genetics and biology of an individual's inherited risk of disease and progression of disease is growing. Physicians are increasing using tests and technology, including Germline Genetic, Genomic, and Biomarker Testing, to provide insight into a healthy individual's risk and an affected individual's disease characteristics, in order to provide individualized clinical treatments. However, many barriers to widespread and appropriate Germline Genetic, Genomic, and Biomarker Testing persist due to complex guidelines for use, varied quality and cost, rapid advances, and adequate understanding of appropriate implementation by medical professionals. The iGAP Registry is a multi-center ongoing database designed to capture information on disease risk assessment, Germline Genetic, Genomic, and Biomarker Testing, and their utilization and impact on treatment practices and outcomes to help determine, over time, the most effective use of testing in varied patient populations and to support the increased use of precision medicine. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04419896
Study type Observational [Patient Registry]
Source Medneon
Contact
Status Enrolling by invitation
Phase
Start date January 23, 2019
Completion date January 1, 2030

See also
  Status Clinical Trial Phase
Recruiting NCT03472807 - EXOme Rare Cancers in Children (EXOCARE) N/A
Completed NCT04848142 - Psychosocial Impact of Disclosing Cancer Predisposition Genetic Testing Results During Childhood
Completed NCT03982446 - Germline Mutations in Pancreatic Adenocarcinoma
Not yet recruiting NCT06450171 - Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study N/A